In celebration of the approaching New Year, I present a list of the top ten science stories of 2008. Taken from the vast expanse of all fields of science, they may not be everyone's top ten, but they are among the top news makers and will have repercussions well past the ending days of 2008.
This entry is short for I finished an in depth look at Alzhiemer's disease treatments—the beginning of which can be found here. The section concerning the new drug Rember is here.
However, as a brief summary, 2008 brought with it the promise of a new drug to treat Alzheimer's disease (AD). Created by a British group, Rember is the first drug to tackle the tau tangles that afflict the brains of AD patients. Early tests show highly positive results, and as Rember enters into the important third phase of FDA trials, the world waits for the news of the drug's true effectiveness, information that should be reported sometime in mid-2009.
For a deeper look at this astounding story, please check out my article on the history of AD treatments here.
Check out the rest of the list here.